Table 1 |
|||
|
Relationship between clinical and pathological features and breast carcinomas expressing the immunophenotype CD44+CD24-/low and carcinomas that do not express this immunophenotype |
|||
|
Feature |
CD44+CD24-/low positive |
CD44+CD24-/low negative |
p-value |
|
|
|||
|
Age (years) |
0.789 |
||
|
|
|||
|
< 50 |
38 |
66 |
|
|
|
|||
|
> 50 |
51 |
98 |
|
|
|
|||
|
|
|||
|
Menopausal status |
0.131 |
||
|
|
|||
|
Pre |
38 |
53 |
|
|
|
|||
|
Post |
51 |
111 |
|
|
|
|||
|
|
|||
|
Tumor size (cm) |
0.837 |
||
|
|
|||
|
< 2 |
24 |
49 |
|
|
|
|||
|
2-5 |
39 |
66 |
|
|
|
|||
|
> 5 |
26 |
49 |
|
|
|
|||
|
|
|||
|
Bloom & Richardson |
0.319 |
||
|
|
|||
|
I |
28 |
66 |
|
|
|
|||
|
II |
48 |
73 |
|
|
|
|||
|
III |
13 |
25 |
|
|
|
|||
|
|
|||
|
Clinical Staging |
0.219 |
||
|
|
|||
|
I |
12 |
21 |
|
|
|
|||
|
IIa |
21 |
40 |
|
|
|
|||
|
IIb |
19 |
34 |
|
|
|
|||
|
IIIa |
6 |
20 |
|
|
|
|||
|
IIIb |
22 |
44 |
|
|
|
|||
|
IV |
9 |
5 |
|
|
|
|||
|
|
|||
|
Recurrence |
1.000 |
||
|
|
|||
|
Yes |
11 |
21 |
|
|
|
|||
|
No |
78 |
143 |
|
|
|
|||
|
|
|||
|
Lymph node status |
0.895 |
||
|
|
|||
|
Pos |
47 |
89 |
|
|
|
|||
|
Neg |
42 |
75 |
|
|
|
|||
|
|
|||
|
Distant metastasis |
0.479 |
||
|
|
|||
|
Yes |
30 |
48 |
|
|
|
|||
|
No |
59 |
116 |
|
|
|
|||
|
|
|||
|
Death |
0.035* |
||
|
|
|||
|
Yes |
37 |
46 |
|
|
|
|||
|
No |
52 |
118 |
|
|
|
|||
|
|
|||
|
*Statistically significant. |
|||
|
Oliveira-Costa et al. Diagnostic Pathology 2011 6:73 doi:10.1186/1746-1596-6-73 |
|||
